Brind.

Corporate changes involving Lantern Pharma, Chimerix, and Starlight Therapeutics, including a subsidiary announcement and an acquisition.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Corporate changes involving Lantern Pharma, Chimerix, and Starlight Therapeutics, including a subsidiary announcement and an acquisition.

Who's involved

What this event is mainly about
Chimerix (United States)Oncoceutics (United States)

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WireLantern Pharma Announces Appointment of Dr. Lee Schalop to Board of Directors Seasoned Biotech Executive & Wall Street Analyst Brings Deep Expertise in Precision Neurooncology, Biopharma Partnering a